Globus Medical, Inc. (GMED:NYSE) closed at $72.14 on November 13, 2026, down 0.22% on the day. The stock trades 28.9% below its 52-week high of $101.40 and 2.5% above its 52-week low of $70.40. Over the past year, it lost 14.6%. Globus Medical, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 13, 2025, GMED closed higher on 117 days (46%). Its best day was November 4, 2026 (+9.45%) and its worst was November 6, 2026 (-12.76%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 2 times.
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches. It provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. The company also offers various disruptive technology products that provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies comprising dynamic stabilization, total disc replacement, and interspinous process spacer products; regenerative biologics technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. In addition, it offers human tissue products, such as bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets. The company sells its implants and rela...
Find more stocks like GMED with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.